We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+10.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.03B
AUM Growth
+$258M
(+15%)
Cap. Flow
+$193M
Cap. Flow
% of AUM
9.48%
Top 10 Holdings %
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$39.8M |
| 2 |
AGN
Allergan plc
AGN
|
+$27.2M |
| 3 |
BID
Sotheby's
BID
|
+$17.1M |
| 4 |
VSM
Versum Materials, Inc.
VSM
|
+$16.5M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TVPT
Travelport Worldwide Limited
TVPT
|
+$27.8M |
| 2 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$19M |
| 3 |
Centene
CNC
|
+$15M |
| 4 |
LXFT
Luxoft Holding, Inc.
LXFT
|
+$14.7M |
| 5 |
NAVG
Navigators Group Inc
NAVG
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.64% |
| 2 | Technology | 6.61% |
| 3 | Industrials | 5.39% |
| 4 | Communication Services | 5.27% |
| 5 | Consumer Discretionary | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Green Brick Partners
GRBK
$3.07B
| $17K | ﹤0.01% |
+2,100
| New | +$18.9K |
|
1302
Hawkins
HWKN
$2.71B
| $17K | ﹤0.01% |
800
+390
| +95% | +$7.47K |
|
1303
PUT
Parker-Hannifin
PH
$135B
| $17K | ﹤0.01% |
+100
| New | +$17.2K |
|
1304
Arcus Biosciences
RCUS
$3.61B
| $17K | ﹤0.01% |
+2,198
| New | +$22K |
|
1305
CALL
Starbucks
SBUX
$120B
| $17K | ﹤0.01% |
+200
| New | +$15.7K |
|
1306
CALL
Synchrony
SYF
$25.6B
| $17K | ﹤0.01% |
+500
| New | +$16.9K |
|
1307
United Therapeutics
UTHR
$22.9B
| $17K | ﹤0.01% |
+222
| New | +$20.8K |
|
1308
Viasat
VSAT
$11.3B
| $17K | ﹤0.01% |
+208
| New | +$18.2K |
|
|
KIN
1309
DELISTED
Kindred Biosciences, Inc.
KIN
| $17K | ﹤0.01% |
+1,993
| New | +$17.2K |
|
|
GNMK
1310
DELISTED
GenMark Diagnostics, Inc
GNMK
| $17K | ﹤0.01% |
2,626
+988
| +60% | +$6.96K |
|
1311
PUT
AerCap
AER
$24.4B
| $16K | ﹤0.01% |
+300
| New | +$14.7K |
|
1312
Calix
CALX
$2.36B
| $16K | ﹤0.01% |
2,407
-1,405
| -37% | -$9.49K |
|
1313
Navigator Holdings
NVGS
$1.29B
| $16K | ﹤0.01% |
+1,753
| New | +$18.3K |
|
1314
CALL
VanEck Oil Services ETF
OIH
$1.94B
| $16K | ﹤0.01% |
55
| – | – |
|
1315
Sonos
SONO
$1.83B
| $16K | ﹤0.01% |
1,421
-5,088
| -78% | -$55.9K |
|
|
SCX
1316
DELISTED
The L.S. Starrett Company
SCX
| $16K | ﹤0.01% |
2,421
-2,375
| -50% | -$17.4K |
|
1317
Aldeyra Therapeutics
ALDX
$95.9M
| $15K | ﹤0.01% |
2,420
-160
| -6% | -$1.2K |
|
1318
CNX Resources
CNX
$5.2B
| $15K | ﹤0.01% |
+2,098
| New | +$18.4K |
|
1319
PUT
DexCom
DXCM
$31.3B
| $15K | ﹤0.01% |
+400
| New | +$12.6K |
|
1320
Equity Bancshares
EQBK
$1.05B
| $15K | ﹤0.01% |
+578
| New | +$15.4K |
|
1321
Extreme Networks
EXTR
$3.19B
| $15K | ﹤0.01% |
2,300
-4,498
| -66% | -$29.7K |
|
1322
CALL
Gogo Inc
GOGO
$492M
| $15K | ﹤0.01% |
3,800
-2,200
| -37% | -$10.7K |
|
1323
Repligen
RGEN
$9B
| $15K | ﹤0.01% |
173
+128
| +284% | +$8.72K |
|
1324
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
| $15K | ﹤0.01% |
+275
| New | +$14.8K |
|
|
LABL
1325
PUT
DELISTED
Multi-Color Corp
LABL
| $15K | ﹤0.01% |
300
| – | – |
|
Similar funds
PFBT
CCP
SP
HCS
B
SPC
GPCM
MCM
Prelude Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.
- Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
- Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
- Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
- Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
- Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
- Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
- Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.
Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.